Biology Reference
In-Depth Information
Sharma, G., Mirza, S., Parshad, R., Srivastava, A., Gupta, S.D., Pandya, P., et  al., 2011.
Clinical significance of Maspin promoter methylation and loss of its protein expression
in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression.
Tumor. Biol. 32, 23-32.
Sharma, P., Chinaranagari, S., Patel, D., Carey, J., Chaudhary, J., 2012. Epigenetic inactiva-
tion of inhibitor of differentiation 4 (Id4) correlates with prostate cancer. Cancer Med. 1,
176-186.
Sharpless, N.E., DePinho, R.A., 1999. The INK4A/ARF locus and its two gene products.
Curr. Opin. Genet. Dev. 9, 22-30.
Shaw, R.J., Paez, J.G., Curto, M., Yaktine, A., Pruitt, W.M., Saotome, I., et  al., 2001.
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signalling. Develop. Cell 1,
63-72.
Shellman, Y.G., Park, Y.L., Marr, D.G., Casper, K., Xu, Y., Fujita, M., et al., 2003. Release of
vascular endothelial growth factor from a human melanoma cell line, WM35, is induced
by hypoxia but not ultraviolet radiation and is potentiated by activated Ras mutation. J.
Invest. Dermatol. 121, 910-917.
Sheng, S., Pemberton, P.A., Sager, R., 1994. Production, purification, and characterization of
recombinant maspin proteins. J. Biol. Chem. 269, 30988-30993.
Sheng, X.J., Zhou, Y.Q., Song, Q.Y., Zhou, D.M., Liu, Q.C., 2012. Loss of breast cancer
metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine
receptor 4 expression. Oncol. Rep. 27, 1011-1018.
Sherbet, G.V., 2001. Calcium signalling in Cancer: The Role of Calcium Binding Proteins in
Cell Proliferation, Invasion and Metastasis. CRC Press, Boca Raton, FL.
Sherbet, G.V., 2003. Genetic Recombination in Cancer. Academic Press/Elsevier, London.
Sherbet, G.V., 2006. DNA ploidy and the progression of cancer. In: Sherbet, G.V. (Ed.),
The Molecular and Cellular Pathology of Cancer Progression and Prognosis. Research
Signpost, Trivandrum, pp. 173-198.
Sherbet, G.V., 2009. Metastasis promoter S100A4 is a potentially valuable molecular target
for cancer therapy. Cancer Lett. 280, 15-30.
Sherbet, G.V., 2011a. Growth Factors and Their Receptors in Cell Differentiation, Cancer and
Cancer Therapy. Elsevier,
Sherbet, G.V., 2011b. S100A4 (S100 calcium binding protein A4). Atlas Genet. Cytogenet.
Oncol. Haematol. 15, 877-886.
Sherbet, G.V., Lakshmi, M.S., 1997. The Genetics of Cancer: Genes Associated with Cancer
Invasion, Metastasis and Cell Proliferation. Academic Press, London.
Sherbet, G.V., Patil, D.B., 2006. Molecular progression of ovarian cancer. In: Sherbet, G.V.
(Ed.), The Molecular and Cellular Pathology of Cancer Progression and Prognosis.
Research Signpost, Trivandrum, pp. 130-172.
Shiba-Ishii, A., Kano, J., Morishita, Y., Sato, Y., Minami, Y., Noguchi, M., 2011. High expres-
sion of stratifin is a universal abnormality during the course of malignant progression of
early-stage lung adenocarcinoma. Int. J. Cancer 129, 2445-2453.
Shiohama, A., Sasaki, T., Noda, S., Minoshima, S., Shimizu, N., 2003. Molecular cloning and
expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromo-
somal region. Biochem. Biophys. Res. Commun. 304, 184-190.
Sherwood, V., Recino, A., Jeffries, A., Ward, A., Chalmers, A.D., 2010. The N-terminal
RASSF family: a new group of Ras-association-domain-containing proteins, with emerg-
ing links to cancer formation. Biochem. J. 425, 303-311.
Shi, W.Y., Xiao, D., Wang, L., Dong, L.H., Yan, Z.X., Shen, Z.X., et  al., 2012. Therapeutic
metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR
pathway and induction of autophagy. Cell. Death. Dis. 3, e275.
 
 
Search WWH ::




Custom Search